Cargando…
Effects of Decitabine on the proliferation of K562 cells and the expression of DR4 gene
OBJECTIVE: To investigate the role of DR4 gene in the occurrence, development and prognosis of acute myeloid leukemia (AML), find a new regulatory gene of Decitabine for the treatment of AML, namely DR4 gene, and explore the molecular mechanism of AML in the treatment of AML. METHODS: The methylatio...
Autores principales: | Zhang, Wenhui, Chen, Yuqing, Pei, Xiaohang, Zang, Yuzhu, Han, Shuangyin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5816003/ https://www.ncbi.nlm.nih.gov/pubmed/29472772 http://dx.doi.org/10.1016/j.sjbs.2017.11.036 |
Ejemplares similares
-
Establishment and molecular characterization of decitabine‐resistant K562 cells
por: Wen, Xiang‐Mei, et al.
Publicado: (2019) -
Synergistic inhibitory effects of deferasirox in combination with decitabine on leukemia cell lines SKM-1, THP-1, and K-562
por: Li, Nianyi, et al.
Publicado: (2017) -
CDA gene silencing regulated the proliferation and apoptosis of chronic myeloid leukemia K562 cells
por: Wei, Xiao-Fang, et al.
Publicado: (2018) -
Calcitonin receptor gene expression in K562 chronic myelogenous leukemic cells
por: Mould, Richard, et al.
Publicado: (2003) -
Dihydroartemisinin Inhibits the Proliferation of Leukemia Cells K562 by Suppressing PKM2 and GLUT1 Mediated Aerobic Glycolysis
por: Gao, Peng, et al.
Publicado: (2020)